bioRxiv / medRxiv
open access
CC BY-NC-ND 4.0
Clinical and Molecular Effects of TYK2/JAK1 Inhibition in Dermatomyositis
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Recent advances and future perspectives in small molecule JAK2 inhibitors.#209722
- Vitamin A and Azithromycin for Acne Vulgaris#982415
- DNAJB1-PRKACA Fusion Kinase Peptide Vaccine Combined With Nivolumab and Ipilimumab for Patients With Fibrolamellar Hepatocellular Carcinoma#1150455
- Phase II Study of TAEST16001 in Soft Tissue Sarcoma#858281
- Sirolimus in Graves' Orbitopathy#873488
Record · ID 401699
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive